Lord, Abbett & Co’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $96.4M | Buy |
|
|||||
|
2021
Q2 | $56.6M | Sell |
|
|||||
|
2021
Q1 | $63.4M | Sell |
|
|||||
|
2020
Q4 | $118M | Sell |
|
|||||
|
2020
Q3 | $116M | Buy |
|
|||||
|
2020
Q2 | $26.4M | Buy |
|
|||||
|
2020
Q1 | $23.1M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $7.12M | Buy |
|
|||||
|
2018
Q2 | $5.55M | Sell |
|
|||||
|
2018
Q1 | $4.56M | Buy |
|
|||||
|
2017
Q4 | $3.44M | Sell |
|
|||||
|
2017
Q3 | $3.1M | Sell |
|
|||||
|
2017
Q2 | $2.67M | Sell |
|
|||||
|
2017
Q1 | $2.37M | Sell |
|
|||||
|
2016
Q4 | $2.31M | Sell |
|
|||||
|
2016
Q3 | $5.9M | Buy |
|
|||||
|
2016
Q2 | $4.92M | Buy |
|
|||||
|
2016
Q1 | $3.31M | Sell |
|
|||||
|
2015
Q4 | $7.37M | Buy |
|
|||||
|
2015
Q3 | $1.95M | Sell |
|
|||||
|
2015
Q2 | $5.18M | Sell |
|
|||||
|
2015
Q1 | $14.5M | Buy |
|
|||||
|
2014
Q4 | $9.58M | Buy |
|
|||||
|
2014
Q3 | $2.59M | Sell |
|
|||||
|
2014
Q2 | $4.1M | Buy |
|
|||||
|
2014
Q1 | $3.81M | Buy |
|
|||||
|
2013
Q4 | $3.93M | Buy |
|